Biotech News
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
aptevotherapeutics.gcs-web.com2026-05-06 15:20 EST
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that it will conduct